Kilpest India Limited's subsidiary extends agreement with H S Biolabs Machester

With a vision to increase business in European terittory, Kilpest India Limited's subsidiary company M/s 3B Blackbio Biotech India Ltd has extended the earlier agreement with U.K & Ireland Distributor M/s.H.S.Biolabs Manchester, to cover the European region.

With this increased territory agreement, HS BioLabs will begin selling all TRUPCR® CE IVD Kits across select markets in the European region.

Having already displaced a number of global diagnostic suppliers in the U.K with TRUPCR®, 3B Blackbio expects HS BioLabs to replicate the same success throughout Europe.

The kits offer significant advantages to end users by being simple to use, robust, highly sensitive as well as able to work on a wide range of Real-time PCR machines.

Dhirendra Dubey, CEO of 3B BlackBio, said: "We are very pleased to have established this agreement with HS BioLabs, whose track record of successfully marketing molecular diagnostic products gives us confidence that they are the best partner for our TRUPCR® range."

Harminder Singh, MD of HS BioLabs, said: "We are committed to delivering high quality molecular diagnostic products to improve laboratory testing and workflows. This agreement builds on our extensive knowledge and experience of molecular diagnostics. We are excited to expand into Europe and grow our team and infrastructure. We look forward to a mutually beneficial and successful partnership with 3B BlackBio."

Shares of KILPEST INDIA LTD. was last trading in BSE at Rs.358.6 as compared to the previous close of Rs. 341.55. The total number of shares traded during the day was 18800 in over 105 trades.

The stock hit an intraday high of Rs. 358.6 and intraday low of 358.6. The net turnover during the day was Rs. 6741680.

Source : Equity Bulls

Keywords